Metabolomics,Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

CXCL12 and IGF1 select for cancer cell populations with enhanced bone metastasis ability


ABSTRACT: CXCL12 and IGF1 confer on cancer cells survival advantage. Src potentiates cancer cells' reponse to CXCL12 and IGF1 by strengthening AKT activation. Long-term incubation of CXCL12 and IGF1 select for cancer cells with enhanced Src activity and bone metastasis potential. MDA-MB-231 cells were incubated for three weeks in growth medium of reduced serum concentration (0.2%) with or without CXCL12 (30 ng/ml) and IGF1 (10 ng/ml). Cell populations survive under these condidtions are expanded by regular growth medium with 10% serum. Two biological replicates were profiled for each condition.

ORGANISM(S): Homo sapiens

SUBMITTER: Xiang Zhang 

PROVIDER: E-GEOD-39102 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

Similar Datasets

2012-12-10 | GSE39102 | GEO
2013-11-01 | E-GEOD-43296 | biostudies-arrayexpress
2013-11-01 | GSE43296 | GEO
2008-06-13 | E-GEOD-5168 | biostudies-arrayexpress
2009-01-14 | E-GEOD-12449 | biostudies-arrayexpress
2011-01-13 | E-GEOD-24496 | biostudies-arrayexpress
2022-05-26 | GSE149481 | GEO
2023-01-01 | GSE210584 | GEO
2016-06-10 | E-GEOD-83150 | biostudies-arrayexpress
2016-07-21 | E-GEOD-80233 | biostudies-arrayexpress